Neuphoria Therapeutics Inc. Form ARS: Annual report to security holders
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2008-07-23: Form ARS; Period of report 2007-06-30; Description AUTO-GENERATED PAPER DOCUMENT; Document 9999999997-08-033349.paper.
- 2005-08-29: Form ARS; Period of report 2005-06-30; Description AUTO-GENERATED PAPER DOCUMENT; Document 9999999997-05-037385.paper.
- 2004-09-13: Form ARS; Period of report 2004-06-30; Description AUTO-GENERATED PAPER DOCUMENT; Document 9999999997-04-037080.paper.
- 2004-01-15: Form ARS; Period of report 2003-06-30; Description AUTO-GENERATED PAPER DOCUMENT; Document 9999999997-04-001779.paper.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2008-07-23 | ARS | 2007-06-30 | AUTO-GENERATED PAPER DOCUMENT | 9999999997-08-033349.paper |
| 2005-08-29 | ARS | 2005-06-30 | AUTO-GENERATED PAPER DOCUMENT | 9999999997-05-037385.paper |
| 2004-09-13 | ARS | 2004-06-30 | AUTO-GENERATED PAPER DOCUMENT | 9999999997-04-037080.paper |
| 2004-01-15 | ARS | 2003-06-30 | AUTO-GENERATED PAPER DOCUMENT | 9999999997-04-001779.paper |
| 2002-10-21 | ARS | 2002-06-30 | AUTO-GENERATED PAPER DOCUMENT | 9999999997-02-056882.paper |
| 2002-09-11 | ARS | 2001-06-30 | AUTO-GENERATED PAPER DOCUMENT | 9999999997-02-051473.paper |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |